Surgical management of coronary arterial disease in the elderly

E A Stemmer1, W S Aronow

  • 1Department of Surgery, University of California at Irvine, USA.

Coronary Artery Disease
|August 26, 1998
PubMed

Insights

Coronary revascularization in the elderly prolongs life and improves quality of life. Earlier detection and elective surgery for coronary artery disease (CAD) in older adults can reduce mortality and disability.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Vascular Surgery

Background:

  • Coronary artery disease (CAD) is increasingly prevalent in patients over 65.
  • CAD in the elderly often presents atypically, leading to delayed diagnosis.
  • Coronary revascularization procedures are increasing in octogenarians and nonagenarians.

Purpose of the Study:

  • To evaluate the role and outcomes of coronary artery angioplasty and bypass in the elderly.
  • To discuss the justification for performing revascularization procedures in older patients.
  • To explore strategies for improving outcomes in elderly patients with CAD.

Main Methods:

  • Review of current practices and outcomes for coronary revascularization in elderly patients.
  • Analysis of diagnostic challenges and treatment approaches for CAD in older adults.
  • Discussion of cost-effectiveness and quality-of-life implications.

Main Results:

  • Coronary revascularization in the elderly can significantly prolong life and enhance quality of life.
  • Delayed diagnosis and emergency procedures in the elderly increase operative mortality and costs.
  • Atypical presentation of CAD in older adults contributes to diagnostic delays.

Conclusions:

  • Early detection and elective coronary revascularization can improve outcomes for elderly patients with CAD.
  • Increased efforts in identifying ischemic heart disease in this population are warranted.
  • Despite challenges, revascularization offers benefits over alternative treatments for elderly patients.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...